Follow-The-Filings

Security · featured owners

ENOV Enovis Corporation

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $916K

ENOV (Enovis Corporation) is held in 1 featured 13F book as of 2026 Q2. Mason Hawkins - Southeastern Asset Management is the largest tracked holder by portfolio weight (0.05%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Mason Hawkins - Southeastern Asset Management) · not free-float ownership

  1. Mason Hawkins 0.05%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Mason Hawkins - Southeastern Asset Management 2026 Q2 0.05% Hold 44,258 $916K history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 16 rows shown

Filed Form Detail Links
4 Period Sep 4, 2026 Filing Doc
4 Period Sep 4, 2026 Filing Doc
4 Period Sep 2, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4/A Period Jun 11, 2026 Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 11, 2026 Filing Doc
4 Period Jun 10, 2026 Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 19, 2026 · 9 forms Filing Doc
4 Period May 12, 2026 · 2 forms Filing Doc
4 Period Mar 31, 2026 Filing Doc
4 Period Mar 13, 2026 Filing Doc
4 Period Mar 10, 2026 Filing Doc
4 Period Mar 6, 2026 Filing Doc
4 Period Mar 7, 2026 Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.71B $2.11B $2.25B
Gross profit $0.991B $1.18B $1.35B
Gross margin * 58.0% 56.0% 59.8%
Net income -$0.033B -$0.825B -$1.18B
Net margin * -1.9% -39.2% -52.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.897B $1.15B $1.21B
Total non-current assets * $3.61B $3.57B $2.63B
Total assets $4.51B $4.72B $3.83B
Total current liabilities $369.61M $529M $598.47M
Total non-current liabilities * $0.719B $1.63B $1.74B
Total equity $3.42B $2.56B $1.49B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $134.99M $113.5M $217.29M
Cash from investing -$242.47M -$955.47M -$179.37M
Cash from financing $127.8M $846.82M -$52.4M
Net change in cash $20.54M $3.34M -$11.78M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders